QUIDELORTHO CORP Marketable Securities (Current)
QUIDELORTHO CORP (QDEL) had Marketable Securities (Current) of $0 as of 2024-12-29, per its 10-K filed 2025-02-27.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-02-27
- 2024-12-29: Marketable Securities, Current $0.00.
- 2024-09-29: Marketable Securities, Current $0.00.
- 2024-06-30: Marketable Securities, Current $0.00.
- 2024-03-31: Marketable Securities, Current $0.00.
| Period end | Marketable Securities, Current |
|---|---|
| 2024-12-29 | $0.00 10-K · filed 2025-02-27 |
| 2024-09-29 | $0.00 10-Q · filed 2024-11-08 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 |
| 2023-12-31 | $48.40M 10-K · filed 2025-02-27 |
| 2023-10-01 | $43.90M 10-Q · filed 2023-11-02 |
| 2023-07-02 | $45.10M 10-Q · filed 2023-08-09 |
| 2023-04-02 | $42.80M 10-Q · filed 2023-05-04 |
| 2023-01-01 | $52.10M 10-K/A · filed 2024-08-01 |
| 2022-10-02 | $51.80M 10-Q · filed 2022-11-04 |
| 2022-07-03 | $52.50M 10-Q · filed 2022-08-05 |
| 2022-01-02 | $25.70M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |